Azido-thalidomide is a building block in the synthesis of proteolysis-targeting chimera (PROTAC) technologies.1 It contains thalidomide, which is a ligand for the E3 ubiquitin ligase cereblon, and can be conjugated to alkynylated ligands for target proteins via click chemistry. Azido-thalidomide has been used in the synthesis of a SirReal-based PROTAC for the degradation of sirtuin 2 (Sirt2) in cells.
1.Schiedel, M., Herp, D., Hammelmann, S., et al.Chemically induced degradation of Sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals)J. Med. Chem.61(2)482-491(2018)
















